Lung cancer immunotherapy: the need for predictive biomarkers

As explained here by James Spicer, PhD, FRCP, of Guy's and St Thomas' NHS Foundation Trust, London, UK, the field of lung cancer research is currently dominated by immunotherapy. Prof. Spicer highligh... Author: VJOncology Added: 03/16/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts